Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetics in ophthalmology: molecular blueprints of retinoblastoma. | Hum Genomics | 2023 | 37658463 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of human non-hematopoietic bone marrow cells reveals a unique set of inter-species conserved biomarkers for native mesenchymal stromal cells. | Stem Cell Res Ther | 2023 | 37649081 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment. | Life (Basel) | 2023 | 37629496 | PubTator, text mining | PubMed |
| Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer. | Diagnostics (Basel) | 2023 | 37627900 | PubTator, text mining | PubMed |
| The ARF GTPase regulatory network in collective invasion and metastasis. | Biochem Soc Trans | 2023 | 37622523 | PubTator, text mining | PubMed |
| Evaluation and optimization of the syndromic management of female genital tract infections in Nairobi, Kenya. | BMC Infect Dis | 2023 | 37608250 | PubTator, text mining | PubMed |
| Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments. | J Biomed Sci | 2023 | 37605155 | PubTator, text mining | PubMed |
| Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review. | Mol Med | 2023 | 37605113 | PubTator, text mining | PubMed |
| MALAT1 in Liquid Biopsy: The Diagnostic and Prognostic Promise for Colorectal Cancer and Adenomas? | Int J Gen Med | 2023 | 37601809 | PubTator, text mining | PubMed |
| Editorial: Cancer cell-intrinsic and -extrinsic factors affecting tumor immune evasion. | Front Immunol | 2023 | 37588591 | PubTator, text mining | PubMed |
| Fibroblast activation in response to TGFβ1 is modulated by co-culture with endothelial cells in a vascular organ-on-chip platform. | Front Mol Biosci | 2023 | 37577751 | PubTator, text mining | PubMed |
| Low level ALK FISH positive results should be approached with caution and confirmed by an orthogonal method. | Transl Lung Cancer Res | 2023 | 37577303 | PubTator, text mining | PubMed |
| Advances in the Early Detection of Hepatobiliary Cancers. | Cancers (Basel) | 2023 | 37568696 | PubTator, text mining | PubMed |
| CCIDB: a manually curated cell-cell interaction database with cell context information. | Database (Oxford) | 2023 | 37566630 | PubTator, text mining | PubMed |
| Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer. | Medicine (Baltimore) | 2023 | 37565899 | PubTator, text mining | PubMed |
| Gamma glutamyl transferase as a biomarker to predict contrast-induced nephropathy among patients with acute coronary syndrome undergoing coronary interventions: a meta-analysis. | Ann Med Surg (Lond) | 2023 | 37554858 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk RNA-seq establishes a novel signature for prediction in gastric cancer. | World J Gastrointest Oncol | 2023 | 37546563 | PubTator, text mining | PubMed |
| Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers. | Cancer Biomark | 2023 | 37545218 | PubTator, text mining | PubMed |
| Comprehensive analysis of CPSF4-related alternative splice genes in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | 37542549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=22